Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy Robson

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Seminars in Thrombosis and Hemostasis|November 23, 2017
Emerging Roles for von Willebrand Factor in Cancer Cell BiologyJamie M O'Sullivan, Roger J S Preston, Tracy Robson, et al.
Cardiovascular Research|September 17, 2005
Pericytes influence endothelial cell growth characteristics: role of plasminogen activator inhibitor type 1 (PAI-1)Marie McIlroy, Martin O'Rourke, Stephanie R McKeown, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 3, 2019
Delivery of RALA/siFKBPL nanoparticles via electrospun bilayer nanofibres: An innovative angiogenic therapy for wound repairEoghan J Mulholland, Ahlam Ali, Tracy Robson, et al.
The Journal of Gene Medicine|May 2, 2007
Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancerHelen O McCarthy, Jonathan A Coulter, Jenny Worthington, et al.
Oncology Research|October 20, 2004
Radiosensitization of colon cancer cell lines by docetaxel: mechanisms of actionAmanda L Dunne, Carmel Mothersill, Tracy Robson, et al.
The Journal of Gene Medicine|June 2, 2004
Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatmentJenny Worthington, Helen O McCarthy, Eimear Barrett, et al.
The Journal of Gene Medicine|September 8, 2010
Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancerJonathan A Coulter, Natalie L Page, Jenny Worthington, et al.
International Journal of Pharmaceutics|December 8, 2010
Evaluation of a multi-functional nanocarrier for targeted breast cancer iNOS gene therapyHelen O McCarthy, Alek V Zholobenko, Yuhua Wang, et al.
The Journal of Gene Medicine|December 9, 2008
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cellsCatherine Adams, Helen O McCarthy, Jonathan A Coulter, et al.
International Journal of Cancer|May 31, 2008
Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotypeKarl T Butterworth, Helen O McCarthy, Andrea Devlin, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Seminars in Thrombosis and Hemostasis|November 23, 2017
Emerging Roles for von Willebrand Factor in Cancer Cell BiologyJamie M O'Sullivan, Roger J S Preston, Tracy Robson, et al.
Cardiovascular Research|September 17, 2005
Pericytes influence endothelial cell growth characteristics: role of plasminogen activator inhibitor type 1 (PAI-1)Marie McIlroy, Martin O'Rourke, Stephanie R McKeown, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 3, 2019
Delivery of RALA/siFKBPL nanoparticles via electrospun bilayer nanofibres: An innovative angiogenic therapy for wound repairEoghan J Mulholland, Ahlam Ali, Tracy Robson, et al.
The Journal of Gene Medicine|May 2, 2007
Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancerHelen O McCarthy, Jonathan A Coulter, Jenny Worthington, et al.
Oncology Research|October 20, 2004
Radiosensitization of colon cancer cell lines by docetaxel: mechanisms of actionAmanda L Dunne, Carmel Mothersill, Tracy Robson, et al.
The Journal of Gene Medicine|June 2, 2004
Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatmentJenny Worthington, Helen O McCarthy, Eimear Barrett, et al.
The Journal of Gene Medicine|September 8, 2010
Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancerJonathan A Coulter, Natalie L Page, Jenny Worthington, et al.
International Journal of Pharmaceutics|December 8, 2010
Evaluation of a multi-functional nanocarrier for targeted breast cancer iNOS gene therapyHelen O McCarthy, Alek V Zholobenko, Yuhua Wang, et al.
The Journal of Gene Medicine|December 9, 2008
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cellsCatherine Adams, Helen O McCarthy, Jonathan A Coulter, et al.
International Journal of Cancer|May 31, 2008
Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotypeKarl T Butterworth, Helen O McCarthy, Andrea Devlin, et al.
Pageof 8